Pain relief for menstrual cramps using taVNS
Official title: A Randomized Two-Way Crossover Comparison Study of Pain Relief From Dysmenorrhea Employing taVNS and Sham Stimulation
Run by University of Electronic Science and Technology of China · NCT06912386 · Data updated 2026-11-12
This study is testing if a new treatment called taVNS can help women with moderate menstrual cramps feel less pain and rely less on medication during their periods.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 20 (estimated) |
| Sponsor | University of Electronic Science and Technology of China Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | June 30, 2025 |
| Study ends | June 30, 2025 |
| Registry record updated | April 4, 2025 |
| Trial ID | NCT06912386 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women with regular menstrual cycles experiencing moderate dysmenorrhea who have used over-the-counter pain relief.
✕Probably not a fit
Patients with secondary dysmenorrhea or those on oral contraceptives may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of transauricular vagal nerve stimulation (taVNS) in alleviating moderate dysmenorrhea. Participants will undergo taVNS for two months and a sham stimulation for another two months, with treatments starting two days before their menstrual cycle. They will keep a diary to track pain levels and medication use, and will attend clinic visits for assessments. The study aims to determine if taVNS can reduce the need for rescue medication during menstruation.
Why it matters
Potential benefit: If successful, this approach could provide a non-pharmacological option for managing menstrual pain.
How similar studies have gone: While the use of taVNS is a novel approach for dysmenorrhea, similar techniques have shown promise in other pain management studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Regular menstrual cycle (28 days ± 7 days); * Average moderate menstrual pain (with 4 - 7 NRS scores); * History of over-the-counter (OTC) analgesic use for the treatment of menstrual pain (at least 1 IBUPROFEN for the first two days); * 4 consecutive monthly menstrual cycles; * Non-pregnant status; * Agrees to use adequate birth control during the trial; * Otherwise, healthy; * Agree not to participate in any other clinical trial while enrolled in this trial ; * No facial or ear pain, no recent ear trauma, no metal implants including pacemakers; * Normal ECG, Heart Rate and Blood Pressure (systolic BP 105-130, diastolic BP 60-90, heart rate per min at rest 60-85); Exclusion Criteria: * Currently under medications (except for analgesic medication for menstrual cycle); * Use of oral contraceptive; * Secondary cause for dysmenorrhea (i.e., endometriosis, adenomyosis, uterine fibroids, or infection); * Unstable or serious illness (e.g., kidney, liver, GIT, heart conditions, diabetes, thyroid gland function, lung conditions, chronic asthma, diagnosed psychological or mood disorder, hypertension, any bleeding disorders, recent surgery, or concurrent blood thinning treatment); * Current malignancy or treatment for malignancy within the previous 2 years; * Pregnant or lactating women; * Active smokers, nicotine use, or drug (prescription or illegal substances) abuse; * Chronic past and/or current alcohol use (\>14 alcoholic drinks per week); * Any condition that in the opinion of the investigator, makes the participant unsuitable for inclusion; * Unwilling or unable to comply with protocol; * Active genitourinary infection in the last four weeks; * Unable to read or comprehend the informed consent; * Unwilling to complete study procedures; * Participated in any other clinical trial during the past 1 month; * Personal or family history of seizure, mood, or cardiovascular disorders; * Allergic reaction to surface electrodes.
Where it's running
-
Uestc
Chengdu, Sichuan, China Recruiting
Study contacts
- Study coordinator: Stefania Ferraro, PhD
- Email: stefania@uestc.edu.cn
- Phone: +86 18684009672
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nonpharmacologic therapies for menstrual pain in young women with primary dysmenorrhea
This study tests whether vibration therapy, abdominal massage, or myofascial release can help reduce menstrual pain in women aged 18–30 who have primary dysmenorrhea, compared with education alone.
-
High-intensity interval training to reduce menstrual pain and improve menstrual health in women with primary dysmenorrhea
This 12-week program will try supervised online high-intensity interval training plus a menstrual health workshop to see if it reduces menstrual pain and improves quality of life for women aged 18–40 with primary dysmenorrhea.
-
Over-the-counter pain medicine comparison for period cramps in women with Crohn's disease
This pilot will test whether ibuprofen or acetaminophen relieves period cramps more effectively and safely for women aged 18–44 who have Crohn's disease in remission.
-
How pelvic organ pain affects muscles and the automatic nervous system in women with painful periods
We will test whether women with painful periods show bigger muscle and automatic nervous system (heart-rate variability) responses to a brief pelvic pain stimulus than women without painful periods.
-
Effects of kinesiology taping and relaxation techniques on menstrual pain
This study is testing if combining kinesiology taping with relaxation techniques can help women with menstrual pain feel better compared to just using kinesiology taping and a hot pack.
-
Myofascial release technique for menstrual pain relief in women
This study is testing if a special massage technique can help relieve menstrual pain in women aged 18-40.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.